MK-5684

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

End-Stage Kidney DiseaseHealthy ParticipantsKidney Failure, ChronicProstatic NeoplasmsRenal Failure, ChronicRenal Failure, End-Stage

Phase 1

A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)

CompletedNCT06554639

Merck Sharp & Dohme LLCProstatic Neoplasms

Start: 2024-07-11End: 2024-08-29Updated: 2024-10-15

A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)

CompletedNCT06814132

Merck Sharp & Dohme LLCKidney Failure, Chronic, End-Stage Kidney Disease, Renal Failure, Chronic +2

Start: 2025-04-07End: 2025-10-14Updated: 2025-10-23